Antiretroviral Drugs for Treatment and Prevention of HIV in Adults: 2024 Recommendations of the International Antiviral Society–USA Panel
Rajesh T. Gandhi(Harvard University), Michael S. Saag(University of Alabama at Birmingham), Susan Buchbinder(San Francisco Department of Public Health), Donna M. Jacobsen, Davey M. Smith(University of California, San Diego), Roger Bedimo(The University of Texas Southwestern Medical Center), Raphael J. Landovitz(APLA Health), Jean‐Michel Molina(Inserm), Sandra A. Springer(Yale University), Huldrych F. Günthard(University of California San Diego), Clara Lehmann(University of Cologne), Jennifer Hoy(Monash University), Carlos del Rı́o(Emory University), Constance A. Benson(University of Colorado Health), Melanie Thompson(AIDS Research Consortium of Atlanta), Ellen Eaton(University of Alabama at Birmingham), Paul E. Sax(Brigham and Women's Hospital), Joseph J. Eron(University of North Carolina at Chapel Hill), Brenda Crabtree‐Ramírez(Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán)
Cited by 197
Related Papers
Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the <i>CKR5</i> Structural Gene
|Science|1996|2.5k
Antiretroviral Treatment of Adult HIV Infection
|JAMA|2012|2.5k
Recovery of Replication-Competent HIV Despite Prolonged Suppression of Plasma Viremia
|Science|1997|2.2k
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection
|New England Journal of Medicine|2015|1.6k
Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival
|New England Journal of Medicine|2009|1.1k